论文部分内容阅读
目的分析急性心肌梗死病种全程医疗质量管理影响因素,提高该病种的救治和管理水平。方法选取2012年全部进行病种质量监控的226例急性心肌梗死病例为监控组、2011年同期未监控的193例为非监控组,对结果质量指标和环节质量指标进行综合比较、评价。结果监控组与非监控组的危重病例率相等(P>0.05),监控组在治愈好转率、平均住院日、低密度脂蛋白胆固醇评估、健康教育等方面,均优于非监控组(P<0.05);药物溶栓和一般治疗的患者平均费用、药物溶栓时间、24小时内左心室功能评价完成率均有改善,但差异不明显(P>0.05)。结论采用流程再造、科室培训、临床路径应用、病历质量监控、追踪检查法和品管圈等措施,可持续改进急性心肌梗死病种管理质量。
Objective To analyze the influencing factors of medical quality management in acute myocardial infarction and to improve the treatment and management of the disease. Methods A total of 226 cases of acute myocardial infarction, which were all monitored for disease quality in 2012, were selected as the monitoring group and 193 cases, which were not monitored in the same period of 2011, as the non-monitoring group. The quality indicators and link quality indicators were compared and evaluated comprehensively. Results The critically ill patients in monitoring group and non - monitoring group had the same rate (P> 0.05). The monitoring group was superior to non - monitoring group in terms of cure rate, average length of stay, assessment of LDL cholesterol, and health education (P < 0.05). The average cost of drug thrombolysis and general treatment, thrombolysis time and the completion rate of left ventricular function within 24 hours had no significant difference (P> 0.05). Conclusion The quality of management of acute myocardial infarction (AMI) diseases can be continuously improved through such measures as process reengineering, departmental training, application of clinical pathology, quality control of medical records, follow-up examination and quality control circle.